Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kaleido Biosciences (KLDO)
:KLDO
Holding KLDO?
Track your performance easily
KLDO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.00 - $0.07
Previous CloseN/A
Volume300.00
Average Volume (3M)1.71K
Market Cap
$43.00
Enterprise ValueN/A
Total Cash (Recent Filing)$2.73M
Total Debt (Recent Filing)$4.95M
Price to Earnings (P/E)―
Beta266.83
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,622,560
10 Day Avg. Volume83
30 Day Avg. Volume1,713
Standard Deviation21.79
R-Squared0.00817
Alpha4.40
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
KLDO FAQ
What was Kaleido Biosciences’s price range in the past 12 months?
Kaleido Biosciences lowest stock price was $0.00 and its highest was $0.07 in the past 12 months.
What is Kaleido Biosciences’s market cap?
Kaleido Biosciences’s market cap is $43.00.
When is Kaleido Biosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kaleido Biosciences’s earnings last quarter?
Currently, no data Available
Is Kaleido Biosciences overvalued?
According to Wall Street analysts Kaleido Biosciences’s price is currently Overvalued.
Does Kaleido Biosciences pay dividends?
Kaleido Biosciences does not currently pay dividends.
What is Kaleido Biosciences’s EPS estimate?
Kaleido Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kaleido Biosciences have?
Kaleido Biosciences has 42,622,560 shares outstanding.
What happened to Kaleido Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kaleido Biosciences?
Currently, no hedge funds are holding shares in KLDO
---
Company Description
Kaleido Biosciences
Kaleido Biosciences, Inc. is a healthcare company, which focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA.
---
Atea Pharmaceuticals
―
C4 Therapeutics
―
Kura Oncology
―
Seres Therapeutics
―
Regeneron
―
Alnylam Pharma
―
---